Taylor & Francis Group

Future Science Group

Science EN ↓ 321 episodi

Podcast by Taylor & Francis Group

Visita il sito del podcast e sostieni chi lo crea: soundcloud.com

Autore

Taylor & Francis Group

Categoria

Science

Sito del podcast

soundcloud.com

Ultimo episodio

17 ott 2026

Dove ascoltare?

I podcast nell'app Replaio Radio In arrivo

I podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast

Scaricala su Google Play Installala gratis Android quasi 10 mln di download · valutazione 4,8 iOS in arrivo

Episodi

Tech Blast | Comprehensive genomic profiling in cancer 13.09.2022

In this Tech Blast episode, our Digital Editor Annie Coulson talks with Carlo Messina, Senior Director for Oncology in Global Development and Medical Affairs at Roche (Basel, Switzerland), about the use of comprehensive genomic profiling (CGP) in cancer research. CGP can obtain more information about a tumor from a smaller biospecimen compared with other genomic profiling techniques and gives onco...

3D cell cultures: the latest developments, applications and regulations in the field 26.08.2022

In this episode, supported by BrandTech, returning guest Rob Vries, CEO of HUB organoids (Utrecht, The Netherlands), fills us in on the advancement of 3D cell cultures and organoids over the last 2 years, starting off by documenting how the pandemic impacted their development and uptake. We also discuss how the recent FDA Modernization Act, removing the requirement for drug candidates to be tested...

Editor's Picks | August 25.08.2022

In this episode of Editor’s Picks, presented by guest-host Grace Tyrrell, learn about how the need for vaccine refrigeration could be on the way out, a new chemical approach that may aid in the fight against antibiotic resistance and the use of AI algorithms as a potential cure for drug-resistant epilepsy.

The potential of autoantibodies in the early detection of cancer 24.08.2022

Welcome to OC talks, a podcast series exploring the latest advancements in oncology. I’m your host, Jade Parker, Oncology Central’s Senior Editor. In this episode, supported by Sengenics, we will be exploring the importance of autoantibodies in the development of cancer as well as how they can be used in the early detection of tumors. Joining me for this episode is Field Application Scientist Jose...

BZ PPD Spotlight Podcast: an interview with Cyrille Bonhomme 17.08.2022

BZ PPD Spotlight Podcast: an interview with Cyrille Bonhomme by Taylor & Francis Group

rAAVs, host cell contamination and ddPCR 03.08.2022

In this episode of Talking Techniques, supported by Bio-Rad, we discuss a key component of many gene therapies: recombinant adeno-associated viruses (rAAVs) and their production. These viruses act as efficient, accurate delivery vesicles for the gene therapy’s plasmid. Speaking to Associate Director of Biopharma Product Marketing at Bio-Rad Laboratories, Mark White, we take a look the di...

Editor's Picks | July 29.07.2022

In this episode of Editor’s Picks, hosted by our Assistant Editor Aisha Al-Janabi, learn about recent concerns over the validity of a pivotal Alzheimer’s disease study, how researchers answered a question about the heart dating back to the 1600s and a laser-based diamond sensing technology that improves magnetoencephalography precision.

HPV, epigenetics and cancer: sequencing for new insights and to correct healthcare inequality 28.07.2022

In many regions of the world, HPV and its association with cervical cancer is a well-known but rarely considered issue, after the rollout of the HPV vaccine in the late 2000s. However, while this rollout significantly impacted cervical cancer rates where it was implemented, it was not universal and in many areas of the world HPV induced cervical cancer remains a critical issue. Cervical cancer is...

Artificial intelligence in healthcare 20.07.2022

Recently, the Alliance for Artificial Intelligence in Healthcare (AAIH) published "The Lifecycle of an AI System in Healthcare", a whitepaper defining what healthcare is and provides guidelines on implementing artificial intelligence (AI) and machine learning (ML) in this setting. In this episode of Talking Techniques, we speak with Oscar Rodriguez, a board member at AAIH and one of the authors of...

Artificial intelligence in healthcare 08.07.2022

Recently, the Alliance for Artificial Intelligence in Healthcare (AAIH) published "The Lifecycle of an AI System in Healthcare", a whitepaper defining what healthcare is and provides guidelines on implementing artificial intelligence (AI) and machine learning (ML) in this setting. In this episode of Talking Techniques, we speak with Oscar Rodriguez, a board member at AAIH and one of the authors of...

Editor's Picks | June 01.07.2022

Welcome to our newest podcast series, Editor's Picks, where we'll round up the latest life science news from BioTechniques. In this bitesize podcast, we've got everything from the history of cephalopods in neuroscience research to recent advancements against antibiotic-resistant bacteria.

Mitigation strategies for the biological matrix supply chain: an interview with Mark O'Dell 29.06.2022

Mitigation strategies for the biological matrix supply chain: an interview with Mark O'Dell by Taylor & Francis Group

Tech Blast | Sculpting bioinformatics workflows for NGS data analysis 08.06.2022

In this episode, supported by Zymo Research, guest host Georgia Bickerton explores NGS data and how bioinformatic pipelines and workflows can be optimized to make NGS data more accessible. To do this she speaks with Jeffrey Bhasin, Director of Informatics at Zymo Research, who discusses the key issues of reproducibility in bioinformatics, the selection of methods available to analyze different dat...

ADA assay development: a podcast interview with Lynn Kamen 06.06.2022

ADA assay development: a podcast interview with Lynn Kamen by Taylor & Francis Group

Liquid biopsy and cfNAs: driving forward diagnostics and disease research 26.05.2022

The key diagnostic and prognostic information locked away in cell-free nucleic acids (cfNAs) has become increasingly accessible due to developments in genetic and epigenetic profiling techniques. These advances have engendered the rise of liquid biopsy techniques, which capture and analyze cfNAs from samples such as blood, saliva, urine and feces, in diagnostics and basic disease research. However...

Liquid biopsy and cfNAs: driving forward diagnostics and disease research 23.05.2022

The key diagnostic and prognostic information locked away in cell-free nucleic acids (cfNAs) has become increasingly accessible due to developments in genetic and epigenetic profiling techniques. These advances have engendered the rise of liquid biopsy techniques, which capture and analyze cfNAs from samples such as blood, saliva, urine and feces, in diagnostics and basic disease research. However...

Tech Blast | Organ-on-a-chip models of fatty liver disease 19.05.2022

In this Tech Blast episode, we discuss preclinical models of non-alcoholic fatty liver disease with Gareth Guenigault, Lead Scientist of Services at CN Bio (Cambridge, UK). Gareth provides an overview of non-alcoholic steatohepatitis (NASH) therapeutic landscape and explains how incorporating organ-on-a-chip models into drug discovery workflows can improve this landscape. Get Gareth’s expert insig...

FON-2021-1277 OCTalks 26.04.2022

FON-2021-1277 OCTalks by Taylor & Francis Group

The evolution of recombinant antibodies 19.04.2022

In this episode, we discuss recombinant proteins: what are they and what are they used for? BioTechniques Editor Tristan Free speaks to Amy Sheng, Technical Account Manager at Sino Biological, who explains the history of recombinant proteins and how protein modeling techniques such as AlphaFold are changing their development. Find out how monoclonal antibodies have been used through the COVID-19 p...

Tech Blast | Microbiome data 19.04.2022

In this Tech Blast episode, we discuss generating, standardizing and sharing microbiome data with Raul Cano, Chief Scientific Officer at The BioCollective. Raul provides a brief overview of the reproducibility crisis and explores how the use of standards and databases can address the challenges it poses. Get Raul’s insight into the field and discover the steps that can be taken to make microbiome...

3D and tea: Dolores Serrano and Katerina Lalatsa on 3D printing in cancer studies 12.04.2022

In this '3D and tea' interview, we speak to Dolores Serrano and Katerina Lalatsa all about the potential of utilizing 3D printing in cancer studies.

NCTalks with Jan Hillert: pregnancy outcomes in MS 06.04.2022

NCTalks with Jan Hillert: pregnancy outcomes in MS by Taylor & Francis Group

Flow cytometry for CGT assay development: an interview with Richard Cuthbert 05.04.2022

Flow cytometry for CGT assay development: an interview with Richard Cuthbert by Taylor & Francis Group

The evolution of iChem workflow automation: a podcast with Andrew Hall 01.04.2022

In this podcast, Andrew Hall (Labcorp, UK) discusses the evolution of large molecule bioanalysis workflow automation as well as the present challenges facing the industry.

Bioanalytical assays for gene therapy programs: an interview with Catherine Vrentas 25.03.2022

Bioanalytical assays for gene therapy programs: an interview with Catherine Vrentas by Taylor & Francis Group

Ascolta il podcast Future Science Group su Replaio

Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio

Scaricala su Google Play

Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici